NCT05322603View on ClinicalTrials.gov

Efficiency and Safety a Fixed Combination of Orphenadrine and Diclofenac for Postoperative Analgesia

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 18, 2022

Primary Completion Date

August 20, 2022

Study Completion Date

August 20, 2022

Conditions
Analgesia
Interventions
DRUG

Analgesics Non Opioid (Neodolpasse manufactured by Fresenius Kabi)

A decrease in the pain severity (VAS);opioid-sparing effect

DRUG

Analgesics

A decrease in the pain severity (VAS)

Trial Locations (1)

Unknown

Petrovsky Research National Centre of Surgery, Moscow

All Listed Sponsors
lead

Petrovsky National Research Centre of Surgery

OTHER